Abstract
Age-related macular degeneration is a multifactorial disease involving inflammation, neovascularization, and vascular leakage. As a result, a rationale exists for investigating combination treatments that target the different pathological processes involved in this disease. We propose triple therapy consisting of verteporfin photodynamic therapy (PDT), intravitreal bevacizumab, and intravitreal dexamethasone. Retrospective chart review. Thirty-two eyes of 30 patients were included. None of the patients demonstrated concurrent eye pathology, and none of the patients had received previous treatment for their choroidal neovascularization. One cycle of triple therapy consisted of reduced-fluence PDT (300 mW/cm(2) for 83 seconds to deliver 25 J/cm(2)) followed immediately by an 800 microg (0.08 mL) intravitreal dexamethasone (IVD) injection. At 1 and 7 weeks after PDT and IVD, patients received a 1.25 mg (0.05 mL) bevacizumab injection. At 13 weeks after PDT and IVD, each patient had a repeat optical coherence tomography and fluorescein angiography to assess choroidal neovascularization activity. Patients were followed for 12 months. The mean number of treatment cycles was 1.4. The mean number of bevacizumab injections was 2.8. Visu...Continue Reading
References
Jun 15, 1993·American Journal of Ophthalmology·K B FreundJ A Sorenson
May 5, 2001·American Journal of Ophthalmology·UNKNOWN Verteporfin In Photodynamic Therapy Study Group
Aug 15, 2003·Ophthalmology·Richard F SpaideLeandro Maranan
Dec 31, 2004·The New England Journal of Medicine·Evangelos S GragoudasUNKNOWN VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group
Apr 11, 2006·Retina·Richard F SpaideMichael J Cooney
May 2, 2006·Ophthalmology·UNKNOWN VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial GroupB Katz
Jun 14, 2006·Retina·Ryan M RichGaurav Kumar
Oct 6, 2006·The New England Journal of Medicine·Philip J RosenfeldUNKNOWN MARINA Study Group
Feb 10, 2007·Retina·Albert J AugustinIndre Offermann
Feb 13, 2007·European Journal of Ophthalmology·R IranmaneshL A Yannuzzi
Mar 28, 2007·American Journal of Ophthalmology·Anne E FungMaria Esquiabro
Jun 9, 2007·BMC Ophthalmology·Hamid AhmadiehSiamak Moradian
Mar 7, 2008·American Journal of Ophthalmology·Andrew N AntoszykUNKNOWN FOCUS Study Group
Oct 16, 2008·Retina·Amparo NaveaElena Palacios
Jan 3, 2009·Ophthalmology·David M BrownUNKNOWN ANCHOR Study Group
May 12, 2009·Retina·Sophie J BakriAlbert O Edwards
Citations
Dec 25, 2010·Eye·Y WangC-C Chan
Dec 5, 2012·Mediators of Inflammation·Francesco ParmeggianiAdolfo Sebastiani
Mar 20, 2013·International Journal of Inflammation·Ishaq A ViringipurampeerKevin Gregory-Evans
Feb 15, 2014·TheScientificWorldJournal·Valentina SaraoPaolo Lanzetta
Jan 13, 2011·Expert Opinion on Drug Delivery·Albert J Augustin
Oct 22, 2013·Progress in Retinal and Eye Research·Patrycja Nowak-SliwinskaAdrian H C Koh
Mar 25, 2015·Journal of Ophthalmology·Makoto IshikawaTakeshi Yoshitomi
Feb 28, 2015·Scientific Reports·N VakalisI Papaefthymiou
Apr 25, 2020·International Journal of Molecular Sciences·Pei-Li YaoGoldis Malek
Oct 30, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jiaxin LiuFengying Sun